Eton Pharmaceuticals Stock Options
| ETON Stock | USD 17.07 0.57 3.23% |
Eton Pharmaceuticals' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.65 with a put-to-call open interest ratio of 0.33 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Eton Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Eton Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Eton Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Eton Pharmaceuticals
Analyzing Eton Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Eton Pharmaceuticals regardless of its overall volatility. This is especially true when Eton Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Eton Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Eton Pharmaceuticals' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Eton Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Eton Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Eton Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Eton Stock moves the wrong way.
Eton Pharmaceuticals In The Money Call Balance
When Eton Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Eton Pharmaceuticals stock is said to be in the money. When it comes to buying Eton Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Eton Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Eton Current Options Market Mood
Eton Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Eton Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Eton Pharmaceuticals' options investors are not very successful. Eton Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Eton contract
Base on the Rule 16, the options market is currently suggesting that Eton Pharmaceuticals will have an average daily up or down price movement of about 0.1% per day over the life of the 2025-03-21 option contract. With Eton Pharmaceuticals trading at USD 17.07, that is roughly USD 0.0176. If you think that the market is fully incorporating Eton Pharmaceuticals' daily price movement you should consider buying Eton Pharmaceuticals options at the current volatility level of 1.65%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Eton |
Purchasing Eton Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Eton calls. Remember, the seller must deliver Eton Pharmaceuticals stock to the call owner when a call is exercised.
Eton Pharmaceuticals Option Chain
When Eton Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Eton Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Eton Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Eton. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Eton. It also shows strike prices and maturity days for a Eton Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ETON250321C00002500 | 0 | 2.5 | 13.1 - 16.5 | 13.1 | In |
Call | ETON250321C00005000 | 3 | 5.0 | 10.6 - 14.1 | 12.4 | In |
Call | ETON250321C00007500 | 0 | 7.5 | 8.1 - 11.6 | 8.1 | In |
Call | ETON250321C00010000 | 0 | 10.0 | 5.6 - 9.1 | 5.6 | In |
Call | ETON250321C00012500 | 0 | 12.5 | 3.3 - 6.8 | 3.3 | In |
Call | ETON250321C00015000 | 1 | 15.0 | 1.25 - 4.8 | 3.2 | In |
Call | ETON250321C00017500 | 24 | 17.5 | 1.7 - 2.55 | 1.85 | Out |
Call | ETON250321C00020000 | 0 | 20.0 | 0.45 - 1.3 | 0.45 | |
Call | ETON250321C00022500 | 1 | 22.5 | 0.0 - 1.25 | 0.7 | Out |
Call | ETON250321C00025000 | 1 | 25.0 | 0.0 - 1.45 | 0.2 | Out |
Put | ETON250321P00002500 | 0 | 2.5 | 0.0 - 1.95 | 1.95 | |
Put | ETON250321P00005000 | 0 | 5.0 | 0.0 - 1.95 | 1.95 | |
Put | ETON250321P00007500 | 0 | 7.5 | 0.0 - 1.95 | 1.95 | |
Put | ETON250321P00010000 | 0 | 10.0 | 0.0 - 1.95 | 1.95 | |
Put | ETON250321P00012500 | 0 | 12.5 | 0.0 - 2.1 | 2.1 | |
Put | ETON250321P00015000 | 10 | 15.0 | 0.0 - 2.55 | 1.0 | Out |
Put | ETON250321P00017500 | 0 | 17.5 | 0.0 - 3.6 | 3.6 | In |
Put | ETON250321P00020000 | 0 | 20.0 | 3.2 - 4.1 | 3.2 | In |
Put | ETON250321P00022500 | 0 | 22.5 | 3.7 - 7.0 | 3.7 | In |
Put | ETON250321P00025000 | 0 | 25.0 | 6.5 - 9.0 | 6.5 | In |
Eton Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Eton Total Stockholder Equity
Total Stockholder Equity |
|
Eton Pharmaceuticals Corporate Management
| Danka Radosavljevic | Senior Operations | Profile | |
| James CPA | Treasurer CFO | Profile | |
| Kevin Guthrie | Executive Operations | Profile | |
| Scott Grossenbach | Vice Operations | Profile | |
| Ingrid Hoos | Senior Affairs | Profile | |
| David Krempa | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share (0.26) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets |
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.